Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-Fat Diet-Induced Obesity Enhances Allograft Rejection.
Molinero LL, Yin D, Lei YM, Chen L, Wang Y, Chong AS, Alegre ML. Molinero LL, et al. Among authors: lei ym. Transplantation. 2016 May;100(5):1015-21. doi: 10.1097/TP.0000000000001141. Transplantation. 2016. PMID: 27007226 Free PMC article.
The composition of the microbiota modulates allograft rejection.
Lei YM, Chen L, Wang Y, Stefka AT, Molinero LL, Theriault B, Aquino-Michaels K, Sivan AS, Nagler CR, Gajewski TF, Chong AS, Bartman C, Alegre ML. Lei YM, et al. J Clin Invest. 2016 Jul 1;126(7):2736-44. doi: 10.1172/JCI85295. Epub 2016 Jun 20. J Clin Invest. 2016. PMID: 27322054 Free PMC article.
Resilience of T cell-intrinsic dysfunction in transplantation tolerance.
Miller ML, McIntosh CM, Wang Y, Chen L, Wang P, Lei YM, Daniels MD, Watkins E, Mora Solano C, Chong AS, Alegre ML. Miller ML, et al. Among authors: lei ym. Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23682-23690. doi: 10.1073/pnas.1910298116. Epub 2019 Nov 4. Proc Natl Acad Sci U S A. 2019. PMID: 31685610 Free PMC article.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
54 results